Washington, DC
Joined January 2014
Jack Corrigan retweeted
International students made up more than 40% of the 500k doctoral degrees awarded by U.S. universities between 2000 and 2019. And stay rates for foreign STEM PhDs are high — over 70% remain in the U.S. @jasonrileywsj cited a 2022 CSET report in his new piece for @WSJopinion.
3
31
3
74
27,051
Jack Corrigan retweeted
The White House just paused ALL visa interviews for foreign students. A disaster for longterm US competitiveness in emerging techs. Five months in, and the damage is adding up. A detailed account of the disruptions to US science, by month. 🧵 /40
Apparently still needs to be said: If we're trying to compete with China in advanced tech, this is *insane*. Even if this specific pause doesn't last long, every anti-international-student policy deters more top talent from choosing the US in years to come. Irreversible damage.
18
78
14
404
82,272
Why does using Huawei's Ascend 910 chip violate U.S. export controls? Think of it as a "secondary violation.” Here's how it works. 🧵👇(1/5) bloomberg.com/news/articles/…
27
51
13
121
42,102
5/ Policymakers can stop this consolidation by fostering a more competitive + diversified AI sector This could entail robust antitrust enforcement, reducing lock-in among CSPs, limiting self-preferencing + bundling, and funding R&D for small models + novel AI paradigms
1
109
Jack Corrigan retweeted
✨New Report✨ Competition is critical for driving innovation in AI, but a new report from CSET’s @_jackcorrigan explores how today’s AI industry may become more concentrated over time—and what policymakers can do to stop it. Read the full report here⬇️ cset.georgetown.edu/publicat…
1
2
1
6
503
15
2,251
26
31,339
704,179
Have you heard of the Bayh-Dole Act? It's niche, but an incredibly important factor in the U.S. innovation ecosystem! For the @TheNatlInterest, @_jackcorrigan and I discuss a potential change that could benefit public access to medical drugs. nationalinterest.org/blog/te…
9
1
12
1,391
4/ Without march-in rights, we lose a key mechanism for keeping corporate power in check, potentially leaving taxpayers paying twice for government-funded inventions—once to fund the research, again through inflated prices. nationalinterest.org/blog/te…
1
1
47
5/ Bottom line: If we want federally funded R&D to actually benefit the public, we can't ignore the prices Americans pay for breakthroughs they helped finance. Check out the full piece here: nationalinterest.org/blog/te…
1
35
Excited to share a new piece @VikramVenkatram and I published today in @TheNatlInterest . I'll warn you, this one's for the nerds. We dive deep into "march-in rights," a wonky but critical legal tool you've probably never heard of 🧵 nationalinterest.org/blog/te…
2
7
7
1,274
3/ Policymakers had recently been trying to make better use of this tool, but the Trump administration now seems poised to abandon those efforts. We think that's a huge mistake nationalinterest.org/blog/te…
1
1
37
2/ "March-in rights" allow the government to step in if companies make inventions—developed with public money—too costly or out of reach. They can be a crucial safeguard against corporate price gouging. nationalinterest.org/blog/te…
1
1
43